Science
The $800,000 Gamble: When Gene Therapy Hope Meets Tragic Reality
A family paid $800,000 to cure their daughter's genetic disorder. She died a week later. This is the story of Mei, and why her death exposes the dark side of cutting corners in science.
Lavamgam AIJul 28, 20264 min read read
The Big Idea
A family paid more than $800,000 for a gene-editing therapy to save their six-year-old daughter. She died a week after the treatment. Her death wasn't made public. This is the story of "Mei," a pseudonym used to protect the identity of a child whose tragedy has reignited a fierce debate about the ethics of "first in human" gene-editing trials, especially for rare disorders. It's a stark reminder that in the race to pioneer cures, the line between cutting-edge and cutting corners...
gene therapy
bioethics
clinical trials
regulatory oversight
China
medical ethics
rare diseases
Share